Sulfatides are associated with neointimal thickening after vascular injury

Atherosclerosis

Volumn 211, Issue 1, 2010, Pages 291-296

  Inoue, T ^a   Taguchi, I ^a   Abe, S ^a   Li, G ^b,c   Hu, R ^b,c   Nakajima, T ^b   Hara, A ^b   Aoyama, T ^b   Kannagi, R ^d   Kyogashima, M ^d,e   Node, K ^f  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HEBEI MEDICAL UNIVERSITY   (China)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e NAGOYA CITY UNIVERSITY   (Japan)

^f SAGA UNIVERSITY   (Japan)

Author keywords

Inflammation; Mac 1; Neointimal thickening; P selectin; Sulfatides

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; CD11B ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PADGEM PROTEIN; SULFATIDE; TICLOPIDINE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTICLE; BARE METAL STENT; BLOOD SAMPLING; BLOOD VESSEL INJURY; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY SINUS; CORONARY STENT; DIAGNOSTIC VALUE; FEMALE; HEART INDEX; HUMAN; IN-STENT RESTENOSIS; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THROMBOCYTE; BLOOD; INFLAMMATION; INTIMA; METABOLISM; MIDDLE AGED; PATHOLOGY; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; INFLAMMATION; MACROPHAGE-1 ANTIGEN; MALE; MIDDLE AGED; P-SELECTIN; STENTS; SULFOGLYCOSPHINGOLIPIDS; TUNICA INTIMA; ANGIOPLASTY, BALLOON, CORONARY;

EID: 77954316022     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.01.033     Document Type: Article

References (30)

1. Liu M.W., Roubin G.S., King S.B. 3rd restenosis after coronary angioplasty: Potential biological determinants and role of intimal hyperplasia. Circulation 1989, 79:1374-1387.
2. Tanaka H., Skhova G.K., Swanson S.J., Clinton S.K., Ganz P., Cybulsky M.I., et al. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 1993, 88(part 1):1788-1803.
3. Welt F.G., Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002, 22:1769-1776.
4. Evangelista V., Manarini S., Rotondo S., Martelli N., Polischuk R., McGregor J.L., et al. Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: Evidence of adhesion cascade and crosstalk between P-selectin and the □2 integrin CD11b/CD18. Blood 1996, 88:4183-4194.
5. Evangelista V., Manarini S., Sideri R., Rotondo S., Martelli N., Piccoli A., et al. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: Role of PSGL-1 as a signaling molecule. Blood 1999, 93:876-885.
6. Simon D.I., Chen Z., Xu H., Li C.Q., Dong J., McIntire L.V., et al. Platelet glycoprotein Ib□ is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000, 192:193-204.
7. Inoue T., Sakai Y., Morooka S., Hayashi T., Takayanagi K., Takabatake Y. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996, 28:1127-1233.
8. Inoue T., Sakai Y., Hoshi K., Yaguchi Y., Fujito T., Morooka S. Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty. Circulation 1998, 97:2511-2518.
9. Inoue T., Sohma R., Miyazaki T., Iwasaki Y., Yaguchi T., Morooka S. Activation process of platelets and neutrophils after coronary stent implantation: Comparison with balloon angioplasty. Am J Cardiol 2000, 86:1057-1062.
10. Inoue T., Uchida T., Yaguchi I., Sakai Y., Takayanagi K., Morooka S. Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation 2003, 107:1757-1763.
11. Bajorath J., Hollenbaugh D., King G., Harte W., Eustice D.C., Darveau R.P., et al. CD62/P-selectin binding sites for myeloid cells and sulfatides are overlapping. Biochemistry 1994, 33:1332-1339.
12. Merten M., Beythien C., Gutensohn K., Kuhnl P., Meinertz T., Thiagarajan P. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation. Arterioscler Thromb Vasc Biol 2005, 25:258-263.
13. Kyogashima M., Sakai T., Onaya J., Hara A. Roles of galactose and sulfate residues in sulfatides for their antagonistic functions in the blood coagulation system. Glycoconj J 2001, 18:245-251.
14. Kyogashima M., Onaya J., Hara A., Taketomi T. Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model. Glycoconj J 1998, 15:915-922.
15. Kyogashima M., Onaya J., Hara A., Taketomi T. Contradictory functions of sulfatide in the blood coagulation system as coagulant and anticoagulant. Acta Biochim Pol 1998, 45:493-499.
16. Mitropoulos K.A., Reeves B.E., Miller G.J. The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins. Blood Coagul Fibrinolysis 1993, 4:943-951.
17. Hara A., Taketomi T. Characterization and changes of glycosphingolipids in the aorta of the Watanabe hereditable hyperlipidemic rabbit. J Biochem 1991, 109:904-908.
18. Shimazawa M., Kondo K., Hara H., Nakashima M., Umemura K. Sulfatides, L- and P-selectin ligands, exacerbate the intimal hyperplasia occurring after endothelial injury. Eur J Pharmacol 2005, 520:118-126.
19. Sugiyama E., Hara A., Uemura A. A quantitative analysis of serum sulfatides by matrix-assisted laser desorption ionization time-of-flight mass spectrometry with delayed ion extraction. Anal Biochem 1999, 274:90-97.
20. American College of Cardiology/American Heart Association Task Force, Group Guideline for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/American Heart Association task force of diagnostic and therapeutic cardiovascular procedures (subcommittee on percutaneous transluminal coronary angioplasty). Circulation 1988, 78:486-502.
21. Hara A., Radin N.S. Lipid extraction of tissues with a low toxicity solvent. Anal Biochem 1978, 90:420-426.
22. Li G., Hu R., Kamijo Y., Nakajima T., Aoyama T., Inoue T., et al. Establishment of a quantitative, qualitative and high throughput analysis of sulfatides from small amounts of sera by MALDI-TOF MS. Anal Biochem 2007, 362:1-7.
23. Inoue T., Sohma R., Morooka S. Cilostazol inhibits the expression of activation-dependent membrane surface glycoprotein on the surface of platelets stimulated in vitro. Thromb Res 1999, 93:137-143.
24. Inoue T., Hikichi Y., Kato T., Morooka T., Yoshida K., Fujimatsu D., et al. Comparison of changes in circulating platelet-derived microparticles and platelet surface P-selectin expression after coronary stent implantation. Platelets 2006, 17:416-420.
25. Inoue T., Sata M., Hikichi Y., Sohma R., Fukuda D., Uchida T., et al. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: Impact on restenosis. Circulation 2007, 115:553-561.
26. Elemer G.S., Edgington T.S. Two independent sets of monoclonal antibodies define neoepitope linked to soluble ligand binding and leukocyte adhesion functions of activated αMβ2. Circ Res 1994, 75:165-171.
27. Chauvet P., Bienvenu J.G., Theoret J.F., Latour J.G., Merhi Y. Inhibition of platelet-neutrophil interactions by fucoidan reduces adhesion and vasoconstriction after acute arterial injury by angioplasty in pigs. J Cardiovasc Pharmacol 1999, 34:597-603.
28. Merten M., Beythien C., Gutensohn K., Kuhnl P., Meinertz T., Thiagarajan P. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation. Arterioscler Thromb Vasc Biol 2005, 25:258-263.
29. Hara A., Taketomi T. Occurrence of sulfatides as a major glycosphingolipid in WHHL rabbit serum lipoproteins. J Biochem 1987, 102:83-92.
30. Inoue T., Node K. Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 2009, 73:615-621.